MedPath

Comparison of the efficiency between Minoxidil 5% or Finasteride 1mg and Minoxidil 5% + Finasteride 1mg in androgenetic alopecia (male pattern) at Hamilton classification scale II - V. - Comparative Efficiency of Finasteride and Minoxidil

Conditions
Alopecia androgenetica
Registration Number
EUCTR2005-005418-19-DE
Lead Sponsor
Dr. med. Bernd Salzer, Private Praxis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Men between 18 and 41 years of age with androgenetic alopecia (male pattern) in state of Hamilton II-V.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Thyroid disease,
Iron-deficiency,
Androgenetic alopecia (female pattern),
Diffuse alopecia,
Alopecia areata,
Drugs that cause hair loss.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Investigation whether Finasteride 1mg is more effective than Minoxidil 5%.;Secondary Objective: Investigation whether Finasteride 1mg + Minoxidil 5% are more effective than the respective monotherapy;Primary end point(s): Investigation whether Finasteride 1mg is more efficient than Minoxidil 5% in hair count and increase of anagen hair in a long-time treatment .
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath